Barbara Pistilli, MD is the Chair of the breast cancer unit at Gustave Roussy. She leads a large translational program focusing on identification of mechanisms of response and resistance to antibody drug conjugates, which include a number of phase I and II trials based on diverse treatment strategies in patients with metastatic solid tumors, with sample collection for exploratory biomarker analysis.
Menu
